vimarsana.com
Home
Live Updates
STEMI Trial Fails to Support Post-PCI Anticoagulation : vima
STEMI Trial Fails to Support Post-PCI Anticoagulation : vima
STEMI Trial Fails to Support Post-PCI Anticoagulation
The randomized RIGHT trial, testing 48 hours of post-PCI anticoagulation in STEMI patients, failed to document either benefit or increased risk.
Related Keywords
Shaoping ,
Jiangxi ,
China ,
Belgium ,
Beijing ,
Chinese ,
Ryan ,
Pascal Vranckx ,
Hartcentrum Hasselt ,
Capital Medical University ,
Critical Care Services ,
Academic Research Consortium ,
European Society Of Cardiology ,
Beijing Anzhen Hospital ,
European Society ,
Nie Shaoping ,
Bleeding Academic Research Consortium ,
Cardiac Critical Care Services ,
Myocardial Infarction ,
Istemi ,
T Segment Elevation Mi ,
St Segment Elevation Myocardial Infarction ,
Percutaneous Coronary Intervention ,
Anticoagulation Therapy ,
Anticoagulant ,
Anticoagulation ,
,
Clinical Research ,
Clinical Trials ,
Linical Studies ,